• In the second quarter of 2026, Redwire Corporation received US$21.5 million in follow-on purchase orders for its Advanced Navigation Stalker Block 30 uncrewed aircraft systems from the U.S. Marine Corps, alongside recent factory expansions in Huntsville and a new space research facility in Georgetown, Indiana.
• By pairing expanded defense UAS production with a new hub for space-enabled pharmaceutical and biotech research, Redwire is pushing into an unusual combination of military and microgravity drug-development capabilities within one portfolio.
• We’ll now examine how the Marine Corps’ follow-on UAS orders could reshape Redwire’s investment narrative around defense and diversification.

AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Redwire Investment Narrative Recap

To own Redwire today, you have to believe it can turn a growing mix of defense UAS and space infrastructure work into more predictable, higher quality revenue despite ongoing losses and volatility. The Marine Corps’ US$21.5 million in follow on Stalker Block 30 orders and the Huntsville expansion reinforce the near term defense production catalyst, but they do not remove the key risk around government contract timing, cost overruns, and lumpy earnings.

The most relevant recent development here is Redwire’s Huntsville, Alabama manufacturing expansion, backed by US$8.5 million in incentives and expected to add about 150 high skilled jobs. That capacity build directly underpins larger UAS orders like the Advanced Navigation Stalker and supports the shift toward more mature production programs, which many investors view as central to improving backlog conversion and smoothing out revenue swings.

Yet against these growth moves, investors should still weigh how Redwire’s heavy use of fixed price contracts and ongoing equity issuance could affect...

Redwire's narrative projects $712.3 million revenue and $62.6 million earnings by 2029. This requires 24.3% yearly revenue growth and a $406.5 million earnings increase from -$343.9 million today.

Uncover how Redwire's forecasts yield a $15.67 fair value, a 74% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts are far more cautious, despite the new Marine Corps awards, assuming revenue climbs to about US$723.1 million by 2029 while warning that supply chain risks and lumpy government funding could still restrain margins and extend losses, so you should compare that pessimistic path with the more optimistic backlog and production story before deciding which narrative feels closer to your own expectations.

Explore 10 other fair value estimates on Redwire - why the stock might be worth over 2x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Redwire research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Redwire research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Redwire's overall financial health at a glance.

Want Some Alternatives?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Find 47 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.